Editorial: real-world safety of tofacitinib in ulcerative colitis
Aliment Pharmacol Ther
.
2022 Feb;55(3):368-369.
doi: 10.1111/apt.16740.
Author
Carlos Taxonera
1
Affiliation
1
Inflammatory Bowel Disease Unit, Department of Gastroenterology, Hospital Clínico San Carlos, and Instituto de Investigación del Hospital Clínico San Carlos [IdISSC], Madrid, Spain.
PMID:
35040163
DOI:
10.1111/apt.16740
No abstract available
Publication types
Editorial
Comment
MeSH terms
Colitis, Ulcerative* / drug therapy
Humans
Piperidines / adverse effects
Pyrimidines / adverse effects
Substances
Piperidines
Pyrimidines
tofacitinib